Testing effectiveness (Phase 2)UnknownNCT05315778What this trial is testingAnti-BCMA CAR T-Cell Therapy for R/R ITPWho this might be right forITP The First Affiliated Hospital of Soochow University 5
Not applicableStudy completedNCT06458803What this trial is testingEfficacy and Safety of Eltrombopag for Refractory Thrombocytopenia Associated With Connective Tissue DiseaseWho this might be right forRefractory ThrombocytopeniaConnective Tissue Diseases Tongji Hospital 52
Testing effectiveness (Phase 2)Study completedNCT03838354What this trial is testingA Clinical Trial of Chidamide in the Management of Refractory ITPWho this might be right forThrombocytopenia Shandong University 61
Not applicableStudy completedNCT01672151What this trial is testingEfficacy of Rapamycin Therapy With Chronic Immune ThrombocytopeniaWho this might be right forImmune Thrombocytopenic Purpura First Affiliated Hospital of Suzhou Medical College 35
Testing effectiveness (Phase 2)UnknownNCT01162941What this trial is testingEfficacy of Helicobacter Pylori Eradication, Anti-D and Danazol Combination in Steroid Dependant or Refractory Immune Thrombocytopenia (ITP)Who this might be right forThrombocytopenia Cooperative Study Group A for Hematology 38
Early research (Phase 1)Study completedNCT00735930What this trial is testingLenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forAnemiaChronic Lymphocytic LeukemiaProlymphocytic Leukemia+3 more National Cancer Institute (NCI) 39
Testing effectiveness (Phase 2)Study completedNCT00102739What this trial is testingSB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)Who this might be right forPurpura, Thrombocytopaenic, Idiopathic GlaxoSmithKline 99
Testing effectiveness (Phase 2)Study completedNCT00706342What this trial is testingPilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)Who this might be right forPurpura, Thrombocytopenic, Idiopathic Rigel Pharmaceuticals 18
Testing effectiveness (Phase 2)Ended earlyNCT05091684What this trial is testingAdministration of Fibrinogen Concentrate for Refractory BleedingWho this might be right forHematological PatientsBleedingPlatelet Refractoriness Centre Hospitalier Universitaire de Saint Etienne 1
Testing effectiveness (Phase 2)Looking for participantsNCT05599880What this trial is testingThe Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune ThrombocytopeniaWho this might be right forRelapsed/Refractory Immune Thrombocytopenia Seoul National University Hospital 29
Testing effectiveness (Phase 2)Looking for participantsNCT06352281What this trial is testingEfficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP)Who this might be right forITP - Immune Thrombocytopenia 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China 10
Not applicableLooking for participantsNCT06973356What this trial is testingAnti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune ThrombocytopeniaWho this might be right forImmune Thrombocytopenia (ITP) Anhui Provincial Hospital 18
Testing effectiveness (Phase 2)Study completedNCT02148133What this trial is testingAssess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic AnemiaWho this might be right forCytopaenia Novartis Pharmaceuticals 21
Very early researchLooking for participantsNCT06337474What this trial is testingAn Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune ThrombocytopeniaWho this might be right forThrombocytopenia Alloimmune Changzhou No.2 People's Hospital 9
Testing effectiveness (Phase 2)UnknownNCT05562882What this trial is testingA Clinical Trial to Assess Safety and Efficacy of Daratumumab in the Treatment of Primary Immune ThrombocytopeniaWho this might be right forImmune Thrombocytopenia Institute of Hematology & Blood Diseases Hospital, China 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07535645What this trial is testingBaricitinib for Post-HSCT Persistent ThrombocytopeniaWho this might be right forPersistent ThrombocytopeniaAllogeneic Hematopoietic Stem Cell Transplantation Peking University People's Hospital 28
Early research (Phase 1)Study completedNCT00001630What this trial is testingTreatment of Autoimmune Thrombocytopenia (AITP)Who this might be right forAutoimmune DiseaseAutoimmune Hemolytic AnemiaThrombocytopenia National Heart, Lung, and Blood Institute (NHLBI) 29
Testing effectiveness (Phase 2)Study completedNCT00065260What this trial is testingRabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic AnemiaWho this might be right forAplastic Anemia National Heart, Lung, and Blood Institute (NHLBI) 54
Early research (Phase 1)Study completedNCT00012376What this trial is testingChemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+15 more National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT00003597What this trial is testingColony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid TumorsWho this might be right forCancer Children's Oncology Group 16